| Isotretinoin | Approved Investigational | ATP6V0B | 533 |
downregulated | Isotretinoin results in decreased expression of ATP6V0B mRNA | 1p34.1 | |
| Isotretinoin | Approved Investigational | ATP6V0C | 527 |
downregulated | Isotretinoin results in decreased expression of ATP6V0C mRNA | 16p13.3 | |
| Isotretinoin | Approved Investigational | ATP6V1D | 51382 |
downregulated | Isotretinoin results in decreased expression of ATP6V1D mRNA | 14q23.3 | |
| Isotretinoin | Approved Investigational | BASP1 | 10409 |
upregulated | Isotretinoin results in increased expression of BASP1 mRNA | 5p15.1 | |
| Isotretinoin | Approved Investigational | BCAP29 | 55973 |
downregulated | Isotretinoin results in decreased expression of BCAP29 mRNA | 7q22.3 | |
| Isotretinoin | Approved Investigational | BCAP31 | 10134 |
downregulated | Isotretinoin results in decreased expression of BCAP31 mRNA | Xq28 | |
| Isotretinoin | Approved Investigational | BCAT2 | 587 |
downregulated | Isotretinoin results in decreased expression of BCAT2 mRNA | 19q13.33 | |
| Isotretinoin | Approved Investigational | BCKDHB | 594 |
downregulated | Isotretinoin results in decreased expression of BCKDHB mRNA | 6q14.1 | |
| Isotretinoin | Approved Investigational | BCL2 | 596 |
upregulated | Isotretinoin results in increased expression of BCL2 mRNA | 18q21.33 | |
| Isotretinoin | Approved Investigational | BCL2L1 | 598 |
upregulated | Isotretinoin results in increased expression of BCL2L1 mRNA | 20q11.21 | |
| Isotretinoin | Approved Investigational | BDH1 | 622 |
downregulated | Isotretinoin results in decreased expression of BDH1 mRNA | 3q29 | |
| Isotretinoin | Approved Investigational | BEAN1 | 146227 |
downregulated | Isotretinoin results in decreased expression of BEAN1 mRNA | 16q21 | |
| Isotretinoin | Approved Investigational | BEND5 | 79656 |
upregulated | Isotretinoin results in increased expression of BEND5 mRNA | 1p33 | |
| Isotretinoin | Approved Investigational | BGN | 633 |
upregulated | Isotretinoin results in increased expression of BGN mRNA | Xq28 | |
| Isotretinoin | Approved Investigational | BHLHE40 | 8553 |
upregulated | Isotretinoin results in increased expression of BHLHE40 mRNA | 3p26.1 | |
| Isotretinoin | Approved Investigational | BLVRB | 645 |
downregulated | Isotretinoin results in decreased expression of BLVRB mRNA | 19q13.2 | |
| Isotretinoin | Approved Investigational | BPY2 | 9083 |
downregulated | Isotretinoin results in decreased expression of BPY2 mRNA | Yq11.223 | |
| Isotretinoin | Approved Investigational | BRAF | 673 |
downregulated | Isotretinoin results in decreased expression of BRAF mRNA | 7q34 | |
| Isotretinoin | Approved Investigational | BSG | 682 |
downregulated | Isotretinoin results in decreased expression of BSG mRNA | 19p13.3 | |
| Isotretinoin | Approved Investigational | BTBD3 | 22903 |
upregulated | Isotretinoin results in increased expression of BTBD3 mRNA | 20p12.2 | |
| Isotretinoin | Approved Investigational | BTD | 686 |
downregulated | Isotretinoin results in decreased expression of BTD mRNA | 3p25.1 | |
| Isotretinoin | Approved Investigational | BTN3A3 | 10384 |
upregulated | Isotretinoin results in increased expression of BTN3A3 mRNA | 6p22.2 | |
| Isotretinoin | Approved Investigational | C1R | 715 |
upregulated | Isotretinoin results in increased expression of C1R mRNA | 12p13.31 | |
| Isotretinoin | Approved Investigational | C1S | 716 |
upregulated | Isotretinoin results in increased expression of C1S mRNA | 12p13.31 | |
| Isotretinoin | Approved Investigational | C3 | 718 |
upregulated | Isotretinoin results in increased expression of C3 mRNA | 19p13.3 | |